JIAXF yields 3.37% · PFE yields 6.13%● Live data
📍 JIAXF pulled ahead of the other in Year 1
Combined, JIAXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JIAXF + PFE for your $10,000?
Jiangxi Copper Company Limited engages in exploring, mining, smelting, and refining copper in Mainland China, Hong Kong, and internationally. It offers copper cathodes, copper rods and wires, sulphuric acid, and other products, as well as deposit, loan, guarantee, and financing consultation services. It is involved in the processing and sale of copper and hardware electric products; production and sale of non-ferrous metals, rare metals and non-metals, electrolytic copper foil, spiral and copper tubes, copper and enameled wires, other copper pipe products, and cast iron grinding balls; provision of repair, consulting, and transportation services; exploration, mining, selection, and smelting of gold and chemical; project, industrial, and fund investment, investment management, and investment and economic information advisory services; metallurgical chemistry; equipment manufacturing and maintenance activities; and development and production of thermo-electronic semiconductors and appliances. In addition, it engages in the development of chemical technologies; contracting for mining constructions; production and sale of casting products; maintenance of mechanical and electrical equipment; installation and debugging of equipment; sale of building materials; production of copper sulfate and electrolytic copper; scrap of base metals; and geological investigation and survey, and construction and engineering measurement. Further, it is involved in the sale of mineral processing, fine chemical, and other industrial and domestic products; trading of metal products; machinery processing; manufacture and sale of wear resistant materials; and trade and settlement of import-export business, offshore investment and financing, cross-border RMB settlement, and research and development activities. The company was founded in 1979 and is headquartered in Nanchang, China.
Full JIAXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.